Cytosorbents (CTSO) EPS (Diluted) (2014 - 2026)
Cytosorbents (CTSO) EPS (Diluted) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.53 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.31 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.61 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.42 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.64 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.26 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.64 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.05 |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07 |
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.05 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.05 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.13 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.28 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.22 |
| Dec 31, 2021 | -0.21 |
| Sep 30, 2021 | -0.15 |